Infant isolation and cohorting for preventing or reducing transmission of healthcare‐associated infections in neonatal units
Referencias
Additional references
AAP, ACOG. Guidelines for Perinatal Care. Elk Grove Village, Ill: AAP/ACOG, 2012.
Abad C, Fearday A, Safdar N. Adverse effects of isolation in hospitalised patients: a systematic review. Journal of Hospital Infection 2010;76(2):97‐102.
Adams‐Chapman I, Stoll BJ. Neonatal infection and long‐term neurodevelopmental outcome in the preterm infant. Current Opinion in Infectious Diseases 2006;19(3):290‐7.
Bassler D, Stoll BJ, Schmidt B, Asztalos EV, Roberts RS, Trial of Indomethacin Prophylaxis in Preterms Investigators. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009;123(1):313‐8.
Bearman G, Stevens MP. Control of drug‐resistant pathogens in endemic settings: contact precautions, controversies, and a proposal for a less restrictive alternative. Current Infectious Disease Reports 2012;14(6):620‐6.
Centers for Disease Control and Prevention. Healthcare‐associated Infections. www.cdc.gov/hai/progress‐report/index.html2015.
Cheng VC, Tai JW, Chan WM, Lau EH, Chan JF, To KK, et al. Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin‐resistant Staphylococcus aureus in intensive care unit. BMC Infectious Diseases 2010;10:263.
Donovan EF, Sparling K, Lake MR, Narendran V, Schibler K, Haberman B, et al. The investment case for preventing NICU‐associated infections. American Journal of Perinatology 2013;30(3):179‐84.
Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115(4):868‐72.
Ford‐Jones EL, Mindorff CM, Langley JM, Allen U, Navas L, Patrick ML, et al. Epidemiologic study of 4684 hospital‐acquired infections in pediatric patients. Pediatric Infectious Disease Journal 1989;8(10):668‐75.
Garner JS, Favero MS. CDC guidelines for the prevention and control of nosocomial infections. Guideline for handwashing and hospital environmental control, 1985. Supersedes guideline for hospital environmental control published in 1981. American Journal of Infection Control 1986;14(3):110‐29.
Gastmeier P, Schwab F, Geffers C, Ruden H. To isolate or not to isolate? Analysis of data from the German Nosocomial Infection Surveillance System regarding the placement of patients with methicillin‐resistant Staphylococcus aureus in private rooms in intensive care units. Infection Control and Hospital Epidemiology 2004;25(2):109‐13.
McMaster University. GRADEpro [www.gradepro.org]. McMaster University, 2014.
Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Hocevar SN, Edwards JR, Horan TC, Morrell GC, Iwamoto M, Lessa FC. Device‐associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006‐2008. Infection Control and Hospital Epidemiology 2012;33(12):1200‐6.
Hooven TA, Polin RA. Healthcare‐associated infections in the hospitalized neonate: a review. Early Human Development 2014;90 Suppl 1:S4‐6.
Karchmer TB, Durbin LJ, Simonton BM, Farr BM. Cost‐effectiveness of active surveillance cultures and contact/droplet precautions for control of methicillin‐resistant Staphylococcus aureus. Journal of Hospital Infection 2002;51(2):126‐32.
Kaushik A, Kest H, Zauk A, DeBari VA, Lamacchia M. Impact of routine methicillin‐resistant Staphylococcus aureus (MRSA) surveillance and cohorting on MRSA‐related bloodstream infection in neonatal intensive care unit. American Journal of Perinatology 2015;32(6):531‐6.
Klevens RM, Edwards JR, Richards CL, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care‐associated infections and deaths in U.S. hospitals, 2002. Public Health Reports (Washington, D.C.: 1974) 2007;122(2):160‐6.
Koch C, Frederiksen B, Høiby N. Patient cohorting and infection control. Seminars in Respiratory and Critical Care Medicine 2003;24(6):703‐16.
Kullar RA, Vassallo A, Turkel S, Chopra T, Kaye KS, Dhar S. Degowning the controversies of contact precautions for methicillin‐resistant Staphylococcus aureus: A review. American Journal of Infection Control 2016;44(1):97‐103.
Landelle C, Pagani L, Harbarth S. Is patient isolation the single most important measure to prevent the spread of multidrug‐resistant pathogens?. Virulence 2013;4(2):163‐71.
Latour JM, Duivenvoorden HJ, Hazelzet JA, van Goudoever JB. Development and validation of a neonatal intensive care parent satisfaction instrument. Pediatric Critical Care Medicine 2012;13(5):554‐9.
Lawn JE, Wilczynska‐Ketende K, Cousens SN. Estimating the causes of 4 million neonatal deaths in the year 2000. International Journal of Epidemiology 2006;35(3):706‐18.
Manzoni P, De Luca D, Stronati M, Jacqz‐Aigrain E, Ruffinazzi G, Luparia M, et al. Prevention of nosocomial infections in neonatal intensive care units. American Journal of Perinatology 2013;30(2):81‐8.
Moran C, Grussemeyer CA, Spalding JR, Benjamin DK, Reed SD. Comparison of costs, length of stay, and mortality associated with Candida glabrata and Candida albicans bloodstream infections. Am J Infect Control 2010;38(1):78‐80.
Morgan DJ, Diekema DJ, Sepkowitz K, Perencevich EN. Adverse outcomes associated with Contact Precautions: a review of the literature. American Journal of Infection Control 2009;37:85‐93.
O'Donovan DJ. Urinary tract infection in neonates. uptodate.com/contents/urinary‐tract‐infections‐in‐neonates2016.
Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004;114(2):348‐55.
Polin RA, Denson S, Brady MT. Strategies for prevention of health care‐associated infections in the NICU. Pediatrics 2012;129(4):e1085‐93.
Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Rosenberger LH, Hranjec T, Politano AD, Swenson BR, Metzger R, Bonatti H, et al. Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi‐drug‐resistant organisms. Surgical Infections 2011;12(5):345‐50.
Rosenberger LH, Riccio LM, Campbell KT, Politano AD, Sawyer RG. Quarantine, isolation, and cohorting: from cholera to Klebsiella. Surgical Infections 2012;13(2):69‐73.
Saiman L. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. Current Opinion in Pediatrics 2006;18(2):101‐6.
Schulman J, Stricof RL, Stevens TP, Holzman IR, Shields EP, Angert RM, et al. Development of a statewide collaborative to decrease NICU central line‐associated bloodstream infections. Journal of Perinatology 2009;29(9):591‐9.
Schünemann H, Brożek J, Guyatt G, Oxman A, editors. GWG. GRADE handbook for grading quality of evidence and strength of recommendations. Available from www.guidelinedevelopment.org/handbookupdated October 2013.
Scott II RD. The direct medical costs of healthcare‐associated infections in U.S. hospitals. http://www.cdc.gov/HAI/pdfs/hai/Scott_CostPaper.pdf2009.
Siegel JD, Rhinehart E, Jackson M, Chiarello L, the Healthcare Infection Control Practices Advisory Committee. Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings. http://www.cdc.gov/ncidod/dhqp/pdf/isolation2007.pdf2007.
Stone PW. Economic burden of healthcare‐associated infections: an American perspective. Expert Review of Pharmacoeconomics & Outcomes Research 2009;9(5):417‐22.
Tawney A, Semproch L, Lephart P, Valentine K, Thomas R, Asmar BI, et al. Impact of Contact Isolation Precautions on Multi‐Drug Resistant Acinetobacter baumannii in the Pediatric Intensive Care Unit. Infection Control and Hospital Epidemiology 2015;36(9):1108‐10.
